Table 3 Characteristics and examination results of COPD patients in acute exacerbation stage
From: Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study
Aspergillus colonization, n = 23 | Control, n = 69 | p value | |
|---|---|---|---|
Symptom and sign | |||
cough | 20 (87.0%) | 61 (88.4%) | 1.000 |
dyspnea | 14 (60.9%) | 53 (76.8%) | 0.177 |
wheezing | 12 (52.2%) | 11 (15.9%) | 0.001 |
fever | 12 (52.2%) | 28 (40.6%) | 0.344 |
moist rale | 13 (56.5%) | 27 (39.1%) | 0.156 |
wheezing rale | 15 (65.2%) | 26 (38.2%) | 0.031 |
Blood routine | |||
WBC count (× 109/L) | 6.45 ± 2.23 | 7.25 ± 3.57 | 0.319 |
NEUT count (×109/L) | 4.73 ± 2.07 | 4.94 ± 3.28 | 0.771 |
NEUT% (%) | 71.2 ± 13.2 | 65.7 ± 13.0 | 0.092 |
EOS% < 0.5% | 30.4% | 23.2% | 0.487 |
EOS% > 5% | 4.3% | 23.2% | 0.044 |
Arterial blood gas | |||
Pa/Fi | 317 ± 42 | 324 ± 59 | 0.625 |
pH | 7.41 ± 0.03 | 7.38 ± 0.72 | 0.063 |
PaCO2 (mmHg) | 40.3 ± 6.3 | 44.5 ± 10.6 | 0.088 |
PaO2 (mmHg) | 70.5 ± 10.9 | 76.8 ± 15.5 | 0.102 |
Biomarker | |||
CRP (mg/dl) | 3.23 ± 3.51 | 2.53 ± 3.12 | 0.412 |
ESR (mm/h) | 25.3 ± 28.2 | 20.0 ± 20.3 | 0.436 |
Total IgE (IU/ml) | 441 ± 1075 | 282 ± 362 | 0.386 |